USC Kenneth Norris Comprehensive Cancer Center SC-3 — Los Angeles, California

USC Kenneth Norris Comprehensive Cancer Center SC-3 is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

USC Kenneth Norris Comprehensive Cancer Center SC-3 has participated in 1 clinical trials.

Therapeutic areas: ALK-positive Non-small Cell Lung Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USC Kenneth Norris Comprehensive Cancer Center SC-3?

USC Kenneth Norris Comprehensive Cancer Center SC-3 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USC Kenneth Norris Comprehensive Cancer Center SC-3 conducted?

USC Kenneth Norris Comprehensive Cancer Center SC-3 has 1 clinical trials on record. Their work covers ALK-positive Non-small Cell Lung Cancer.

Is USC Kenneth Norris Comprehensive Cancer Center SC-3 accredited by Crixeo Health?

USC Kenneth Norris Comprehensive Cancer Center SC-3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USC Kenneth Norris Comprehensive Cancer Center SC-3?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.